Kazuma Ohyashiki
- Hematology top 0.05%
- Acute Myeloid Leukemia Research 146
- Chronic Myeloid Leukemia Treatments 138
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research 94
- Myeloproliferative Neoplasms: Diagnosis and Treatment 33
- Cancer Research top 0.5%
- Molecular Biology top 0.5%
- Aging top 2%
-
- Telomeres, Telomerase, and Senescence 53
-
- Eosinophilic Disorders and Syndromes 50
-
- Lymphoma Diagnosis and Treatment 44
-
- Acute Lymphoblastic Leukemia research 35
- Co-authors
- Junko H. OhyashikiKeisuke ToyamaTomohiro UmezuTetsuzo TauchiChristopher CoxJohn M. BennettMichelle M. LeBeauGuillermo Sanz
- Cited by
- HematologyGeneticsCancer Research
- Journals
- Blood (54 papers)Leukemia Research (31 papers)International Journal of Hematology (26 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Kazuma Ohyashiki
456 papers receiving 13.4k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Hematology 7.0k
- Genetics 3.2k
- Cancer Research 2.1k
- Molecular Biology 6.3k
- Aging 126
Countries citing papers authored by Kazuma Ohyashiki
This map shows the geographic impact of Kazuma Ohyashiki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuma Ohyashiki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuma Ohyashiki more than expected).
Fields of papers citing papers by Kazuma Ohyashiki
This network shows the impact of papers produced by Kazuma Ohyashiki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuma Ohyashiki. The network helps show where Kazuma Ohyashiki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kazuma Ohyashiki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 14 | |
| 2 | 2018 | 15 | |
| 3 | 2018 | 29 | |
| 4 | 2017 | 1 | |
| 5 | 2017 | 1 | |
| 6 | 2013 | 35 | |
| 7 | 2010 | 17 | |
| 8 | 2009 | 257 | |
| 9 | 2007 | 29 | |
| 10 | 2003 | 6 | |
| 11 | 2003 | 11 | |
| 12 | Trisomy 11 acute myeloid leukemia: 5 additional cases from the Japan Adult Leukemia Study Group AML-92 and AML-95 databases. | 2000 | 2 |
| 13 | [Rapidly progressive fibrosis and increased CD68-positive cells in the bone marrow at the terminal stage of adult T-cell leukemia accompanied by polycythemia vera]. | 2000 | 2 |
| 14 | 2000 | 9 | |
| 15 | 2000 | 16 | |
| 16 | [The expression pattern of transcription factors (GATA, SCL) and biological characteristics in various leukemia cells]. | 1995 | 3 |
| 17 | 1994 | 25 | |
| 18 | 1993 | 1 | |
| 19 | 1992 | 13 | |
| 20 | 1990 | 21 |
About Kazuma Ohyashiki
Kazuma Ohyashiki is a scholar working on Hematology, Genetics and Rheumatology, having authored 471 papers that have together received 13.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (146 papers), Chronic Myeloid Leukemia Treatments (138 papers), Chronic Lymphocytic Leukemia Research (94 papers), Telomeres, Telomerase, and Senescence (53 papers), Eosinophilic Disorders and Syndromes (50 papers), Lymphoma Diagnosis and Treatment (44 papers), Acute Lymphoblastic Leukemia research (35 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (33 papers). The work is most often cited by research in Hematology (7.0k citations), Genetics (3.2k citations) and Cancer Research (2.1k citations). Kazuma Ohyashiki has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Junko H. Ohyashiki, Keisuke Toyama, Tomohiro Umezu, Tetsuzo Tauchi, Christopher Cox, John M. Bennett, Michelle M. LeBeau, Guillermo Sanz, Pierre Fenaux and Pierre Morel. Their work appears in journals such as Blood, Leukemia Research, International Journal of Hematology, International Journal of Oncology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.